Cytoselect TM Leukocyte Transm.
Contact us: [email protected]
CytoSelect IdU Competitive ELISA Kit |
CBA-5100 |
Cell Biolabs |
96 assays |
EUR 651.6 |
CytoSelect EdU Competitive ELISA Kit |
CBA-5101 |
Cell Biolabs |
96 assays |
EUR 651.6 |
CytoSelect BrdU Competitive ELISA Kit |
CBA-5098 |
Cell Biolabs |
96 assays |
EUR 651.6 |
CytoSelect™ LDH Cytotoxicity Assay Kit |
CBA-241 |
Cell Biolabs |
960 assays |
EUR 320 |
CytoSelect™ MTT Cell Proliferation Assay |
CBA-252 |
Cell Biolabs |
960 assays |
EUR 320 |
CytoSelect Tumor-endothelium Adhesion Assay |
CBA-215 |
Cell Biolabs |
100 assays |
EUR 692.4 |
Description: Leukocyte or tumor cell interactions with vascular endothelium consist of a cascade of processes including the firm attachment of cells to endothelial cell adhesion molecules. The CytoSelect Tumor Endothelium Adhesion Assay provides a robust system for the quantitative determination of interactions between tumor cells and endothelium. Adherent cells can be easily quantified on a fluorescence plate reader. |
CytoSelect™ 24-well Wound Healing Assay |
CBA-120 |
Cell Biolabs |
24 assays |
EUR 595 |
CytoSelect™ 24-well Wound Healing Assay |
CBA-120-5 |
Cell Biolabs |
5 x 24 assays |
EUR 2465 |
CytoSelect™ BrdU Cell Proliferation ELISA Kit |
CBA-251 |
Cell Biolabs |
96 assays |
EUR 455 |
CytoSelect™ 24-Well Cell Co-Culture System |
CBA-160 |
Cell Biolabs |
24 assays |
EUR 365 |
CytoSelect™ 24-Well Cell Co-Culture System |
CBA-160-5 |
Cell Biolabs |
5 x 24 assays |
EUR 1585 |
CytoSelect™ Cell Viability and Cytotoxicity Assay |
CBA-240 |
Cell Biolabs |
96 assays |
EUR 305 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
CBA-135 |
Cell Biolabs |
96 assays |
EUR 715 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
CBA-135-5 |
Cell Biolabs |
5 x 96 assays |
EUR 3095 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
CBA-140 |
Cell Biolabs |
96 assays |
EUR 750 |
CytoSelect™ Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
CBA-140-5 |
Cell Biolabs |
5 x 96 assays |
EUR 3215 |
CytoSelect™ 96-well Phagocytosis Assay (Zymosan) |
CBA-224 |
Cell Biolabs |
96 assays |
EUR 620 |
CytoSelect™ 96-well Phagocytosis Assay (Zymosan) |
CBA-224-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2670 |
CytoSelect™ 48-Well Cell Contraction Assay Kit |
CBA-5021 |
Cell Biolabs |
48 assays |
EUR 575 |
CytoSelect Cell Proliferation Assay Reagent
(Fluorometric) |
CBA-250 |
Cell Biolabs |
10 mL |
EUR 490.8 |
Description: Cell Biolabs? CytoSelect Cell Proliferation Assay Reagent (Fluorometric) provides a fluorometric format for measuring and monitoring cell proliferation. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then incubated with the proliferation reagent. Upon entering metabolically active live cells, the non-fluorescent proliferation reagent is converted into a bright red fluorescent form. An increase in cell proliferation is accompanied by increased fluorescent signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. The kit contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates. |
CytoSelect 24-well Laminin Cell Invasion, Colorimetric |
CBA-110-LN |
Cell Biolabs |
12 assays |
EUR 714 |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
CytoSelect™ 24-Well Wound Healing Assay, Trial Size |
CBA-120-T |
Cell Biolabs |
6 assays |
EUR 295 |
CytoSelect Clonogenic Tumor Cell Isolation Kit (5 preps) |
CBA-155 |
Cell Biolabs |
5 preps |
EUR 957.6 |
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis. |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
CBA-135-T |
Cell Biolabs |
24 assays |
EUR 518.4 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect™ 96-Well Cell Transformation Assay (Soft Agar Colony Formation), Trial Size |
CBA-130-T |
Cell Biolabs |
24 assays |
EUR 320 |
CytoSelect™ 96-well Phagocytosis Assay (Red Blood Cell) |
CBA-220 |
Cell Biolabs |
96 assays |
EUR 540 |
CytoSelect™ Cell Proliferation Assay Reagent (Colorimetric) |
CBA-253 |
Cell Biolabs |
10 mL |
EUR 320 |
CytoSelect™ 24-well Collagen Cell Invasion, Colorimetric |
CBA-110-COL |
Cell Biolabs |
12 assays |
EUR 535 |
CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit |
CBA-254 |
Cell Biolabs |
96 assays |
EUR 672 |
Description: Cell Biolabs? CytoSelect Proliferating Cell Nuclear Antigen (PCNA) ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of PCNA from nuclear and whole cell extracts. The kit detects PCNA from mouse, rat and human, and has a detection sensitivity limit of 12.5 ng/mLPCNA. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. |
CytoSelect 48-well Cell Adhesion Assay (Laminin, Colorimetric) |
CBA-056 |
Cell Biolabs |
48 assays |
EUR 512.4 |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin. |
CytoSelect 48-well Cell Adhesion Assay (Laminin, Fluorometric) |
CBA-057 |
Cell Biolabs |
48 assays |
EUR 553.2 |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Laminin. |
CytoSelect 24-well Laminin Cell Invasion Assay, Fluorometric |
CBA-111-LN |
Cell Biolabs |
12 assays |
EUR 714 |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
CytoSelect 96-well Laminin Cell Invasion Assay, Fluorometric |
CBA-112-LN |
Cell Biolabs |
96 assays |
EUR 908.4 |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
CytoSelect Clonogenic Tumor Cell Isolation Kit (5 x 5 preps) |
CBA-155-5 |
Cell Biolabs |
25 preps |
EUR 3894 |
Description: Many solid tumors contain heterogeneous populations of normal and cancerous cells. Separation of these cell populations is key to an accurate assessment of the true genotypic and phenotypic differences between normal and tumor cells. Our CytoSelect Clonogenic Tumor Cell Isolation Kit uses a proprietary semisolid agar medium to facilitate formation of colonies by cells from solid tumors. Colonies are grown in either a 6-well plate or a 35mm culture dish. These colonies are isolated away from single (i.e. normal) cells by size filtration. The viable cells from these colonies can be easily recovered for further analysis. |
CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Colorimetric) |
CBA-058 |
Cell Biolabs |
48 assays |
EUR 512.4 |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen. |
CytoSelect 48-well Cell Adhesion Assay (Fibrinogen, Fluorometric) |
CBA-059 |
Cell Biolabs |
48 assays |
EUR 553.2 |
Description: Cell adhesion is a complex process involved in migration/invasion, embryogenesis, wound healing and tissue remodeling. Cells adhere to the extracellular matrix, forming complexes with cytoskeleton components that can affect cell motility, differentiation, proliferation, and survival. Our CytoSelect 48-Well Cell Adhesion Assays provide a fully quantitative method for the evaluation of cell adhesion. The 48-well plate is precoated with Fibrinogen. |
CytoSelect™ 24-well Anoikis Assay (Colorimetric/Fluorometric) |
CBA-080 |
Cell Biolabs |
24 assays |
EUR 505 |
CytoSelect™ 96-well Anoikis Assay (Colorimetric/Fluorometric) |
CBA-081 |
Cell Biolabs |
96 assays |
EUR 525 |
CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric |
CBA-100 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Cell Migration Assay (8 μm), Colorimetric |
CBA-100-5 |
Cell Biolabs |
5 x 12 assays |
EUR 2180 |
CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric |
CBA-101 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Cell Migration Assay (8 μm), Fluorometric |
CBA-101-5 |
Cell Biolabs |
5 x 12 assays |
EUR 2180 |
CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric |
CBA-102 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Cell Migration Assay (5 μm), Fluorometric |
CBA-102-5 |
Cell Biolabs |
5 x 12 assays |
EUR 2180 |
CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric |
CBA-103 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Cell Migration Assay (3 μm), Fluorometric |
CBA-103-5 |
Cell Biolabs |
5 x 12 assays |
EUR 2180 |
CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric |
CBA-104 |
Cell Biolabs |
96 assays |
EUR 580 |
CytoSelect™ 96-well Cell Migration Assay (3 μm), Fluorometric |
CBA-104-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2535 |
CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric |
CBA-105 |
Cell Biolabs |
96 assays |
EUR 580 |
CytoSelect™ 96-well Cell Migration Assay (5 μm), Fluorometric |
CBA-105-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2535 |
CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric |
CBA-106 |
Cell Biolabs |
96 assays |
EUR 580 |
CytoSelect™ 96-well Cell Migration Assay (8 μm), Fluorometric |
CBA-106-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2535 |
CytoSelect™ 24-well Cell Migration Assay (12 μm), Colorimetric |
CBA-107 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Cell Migration Assay (12 μm), Fluorometric |
CBA-108 |
Cell Biolabs |
12 assays |
EUR 480 |
CytoSelect™ 24-well Collagen Cell Invasion Assay, Fluorometric |
CBA-111-COL |
Cell Biolabs |
12 assays |
EUR 535 |
CytoSelect™ 96-well Collagen Cell Invasion Assay, Fluorometric |
CBA-112-COL |
Cell Biolabs |
96 assays |
EUR 705 |
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
CBA-140-T |
Cell Biolabs |
24 assays |
EUR 547.2 |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Colorimetric) |
CBA-070 |
Cell Biolabs |
48 assays |
EUR 515 |
CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Colorimetric) |
CBA-070-5 |
Cell Biolabs |
5 x 48 assays |
EUR 2275 |
CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Fluorometric) |
CBA-071 |
Cell Biolabs |
48 assays |
EUR 555 |
CytoSelect™ 48-well Cell Adhesion Assay (ECM Array, Fluorometric) |
CBA-071-5 |
Cell Biolabs |
5 x 48 assays |
EUR 2430 |
CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Colorimetric) |
CBA-050 |
Cell Biolabs |
48 assays |
EUR 370 |
CytoSelect™ 48-well Cell Adhesion Assay (Fibronectin, Fluorometric) |
CBA-051 |
Cell Biolabs |
48 assays |
EUR 400 |
CytoSelect™ 24-well Cell Invasion (Basement Membrane), Fluorometric |
CBA-111 |
Cell Biolabs |
12 assays |
EUR 535 |
CytoSelect 96-Well Phagocytosis Assay(Zymosan Substrate), Trial Size |
CBA-224-T |
Cell Biolabs |
20 assays |
EUR 463.2 |
Description: Phagocytosis can be assayed by measuring the engulfment of a cell "substrate". However, traditional assays require tedious cell counting under a microscope. Our CytoSelect 96-Well Phagocytosis Assay, Zymosan Substrate provides a more accurate, user-friendly, high-throughput alternative to the standard phagocytosis assay. The assay may be adapted for use with 24-well or 48-well plates. |
CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Colorimetric) |
CBA-052 |
Cell Biolabs |
48 assays |
EUR 370 |
CytoSelect™ 48-well Cell Adhesion Assay (Collagen I, Fluorometric) |
CBA-053 |
Cell Biolabs |
48 assays |
EUR 400 |
CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Colorimetric) |
CBA-060 |
Cell Biolabs |
48 assays |
EUR 370 |
CytoSelect™ 48-well Cell Adhesion Assay (Collagen IV, Fluorometric) |
CBA-061 |
Cell Biolabs |
48 assays |
EUR 400 |
CytoSelect™ 96-Well Phagocytosis Assay (E. coli, Colorimetric Format) |
CBA-222 |
Cell Biolabs |
96 assays |
EUR 595 |
CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (96 assays) |
CBA-320 |
Cell Biolabs |
96 assays |
EUR 440 |
CytoSelect™ 24-Well Cell Contraction Assay Kit (Floating Matrix Model) |
CBA-5020 |
Cell Biolabs |
24 assays |
EUR 495 |
CytoSelect™ 24-well Cell Invasion Assay (Basement Membrane), Colorimetric |
CBA-110 |
Cell Biolabs |
12 assays |
EUR 535 |
CytoSelect™ 96-well Cell Invasion Assay (Basement Membrane), Fluorometric |
CBA-112 |
Cell Biolabs |
96 assays |
EUR 705 |
CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Colorimetric |
CBA-100-FN |
Cell Biolabs |
12 assays |
EUR 505 |
CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), FN-coated, Fluorometric |
CBA-101-FN |
Cell Biolabs |
12 assays |
EUR 505 |
CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Colorimetric |
CBA-100-COL |
Cell Biolabs |
12 assays |
EUR 505 |
CytoSelect™ 24-well Cell Haptotaxis Assay (8 µm), COL-coated, Fluorometric |
CBA-101-COL |
Cell Biolabs |
12 assays |
EUR 505 |
CytoSelect 24-Well Cell Migration Assay (5 µm, Fluorometric Format), Trial Size |
CBA-102-T |
Cell Biolabs |
4 assays |
EUR 358.8 |
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages. |
CytoSelect™ 96-Well Hematopoietic Colony Forming Cell Assay (5 x 96 assays) |
CBA-320-5 |
Cell Biolabs |
5 x 96 assays |
EUR 1885 |
CytoSelect™ 24-Well Cell Migration Assay (8 µm, Colorimetric Format), Trial Size |
CBA-100-T |
Cell Biolabs |
4 assays |
EUR 240 |
CytoSelect™ 24-Well Cell Migration Assay (8 µm, Fluorometric Format), Trial Size |
CBA-101-T |
Cell Biolabs |
4 assays |
EUR 240 |
CytoSelect™ 24-Well Cell Migration Assay (3 µm, Fluorometric Format), Trial Size |
CBA-103-T |
Cell Biolabs |
4 assays |
EUR 240 |
CytoSelect™ 96-well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation) |
CBA-150 |
Cell Biolabs |
96 assays |
EUR 670 |
CytoSelect™ 96-well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation) |
CBA-150-5 |
Cell Biolabs |
5 x 96 assays |
EUR 2935 |
CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit |
CBA-100-C |
Cell Biolabs |
2 x 12 assays |
EUR 915 |
CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Colorimetric, Combo Kit |
CBA-100-C-5 |
Cell Biolabs |
10 x 12 assays |
EUR 3950 |
CytoSelect™ 24-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit |
CBA-101-C |
Cell Biolabs |
2 x 12 assays |
EUR 915 |
CytoSelect™ 96-well Cell Migration and Invasion Assay (8 µm), Fluorometric, Combo Kit |
CBA-106-C |
Cell Biolabs |
2 x 96 assays |
EUR 1080 |
CytoSelect 96-Well In Vitro Tumor Sensitivity Assay (Soft Agar Colony Formation), Trial Size |
CBA-150-T |
Cell Biolabs |
24 assays |
EUR 483.6 |
Description: Traditionally, the soft agar colony formation assay has been used to monitor anchorage-independent growth. Cells proliferate for 3-4 weeks in a semisolid culture medium, followed by tedious manual counting of colonies. Our CytoSelect 96-Well In Vitro Tumor Sensitivity Assay provides a stringent, anchorage-independent model for chemosenstivity testing and screening of potential anticancer drugs. After just 6-8 days, cell colonies are quantified using a standard colorimetric microplate reader. |
CytoSelect™ 24-Well Cell Invasion Assay (Basement Membrane, Colorimetric Format), Trial Size |
CBA-110-T |
Cell Biolabs |
4 assays |
EUR 265 |
CytoSelect™ 24-Well Cell Invasion Assay (Basement Membrane, Fluorometric Format), Trial Size |
CBA-111-T |
Cell Biolabs |
4 assays |
EUR 265 |
Leukocyte Specific Transcript 1 (LST1) Antibody |
abx139945-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
Leukocyte protein |
30-1168 |
Fitzgerald |
5 ml |
EUR 571 |
|
Description: Purified native Human Leukocyte protein |
Human Leukocyte-specific transcript 1 protein (LST1) |
1-CSB-EP013217HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Leukocyte-specific transcript 1 protein(LST1) expressed in E.coli |
Human Leukocyte Specific Transcript 1 (LST1)ELISA kit |
201-12-2295 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Leukocyte Specific Transcript 1 (LST1) ELISA Kit |
abx385091-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
Mouse Leukocyte Specific Transcript 1 (LST1) ELISA Kit |
abx389739-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
Mouse Leukocyte Specific Transcript 1(LST1)ELISA kit |
QY-E20914 |
Qayee Biotechnology |
96T |
EUR 433.2 |
Human Leukocyte Specific Transcript 1(LST1)ELISA Kit |
QY-E04236 |
Qayee Biotechnology |
96T |
EUR 433.2 |
Human Leukocyte Specific Transcript 1 (LST1)ELISA kit |
YLA3025HU-48T |
Shanghai YL Biotech |
48T |
Ask for price |
Human Leukocyte Specific Transcript 1 (LST1)ELISA kit |
YLA3025HU-96T |
Shanghai YL Biotech |
96T |
Ask for price |
Leukocyte Esterase protein |
30-1167 |
Fitzgerald |
1 mL |
EUR 263 |
|
Description: Purified native Human Leukocyte Esterase protein |
LEUKOCYTE ELASTASE, Antibody |
GWB-D078BD |
GenWay Biotech |
0.1 mg |
Ask for price |
Leukocyte elastase inhibitor |
AP79486 |
SAB |
1mg |
EUR 2640 |
|
Leukocyte elastase inhibitor |
AP83930 |
SAB |
1mg |
EUR 2640 |
|
Leukocyte elastase inhibitor |
AP84357 |
SAB |
1mg |
EUR 2640 |
|
Human Leukocyte- specific transcript 1 protein, LST1 ELISA KIT |
ELI-43105h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Mouse Leukocyte- specific transcript 1 protein, Lst1 ELISA KIT |
ELI-22746m |
Lifescience Market |
96 Tests |
EUR 1038 |
Lst1 (untagged) - Mouse leukocyte specific transcript 1 (Lst1), (10ug) |
MC208903 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lst1 (untagged ORF) - Rat leukocyte specific transcript 1 (Lst1), (10 ug) |
RN208501 |
Origene Technologies GmbH |
10 µg |
Ask for price |
CD45 Antibody (Leukocyte marker) |
V8044-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V8044-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V8044SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3656-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3656-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3656IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3656SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3773-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3773-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3773IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3773SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3963-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3963-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3963SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2394-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2394-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2394IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2394SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2399-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2399-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2399IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2399SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2400-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45, B220, LCA and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2400-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45R, also designated CD45, B220, LCA and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2400IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 424.15 |
|
Description: CD45R, also designated CD45, B220, LCA and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2400SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45, B220, LCA and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2401-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2401-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2401IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2401SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. This antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2240-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2240-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2240IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V2240SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45, also referred to as CD45R and PTPRC (Protein tyrosine phosphatase receptor type C), has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Along with other members of the PTP family, it regulates a number of cellular processes including cell differentiation, growth and mitotic cycle, and is an essential regulator of B- and T-cell antigen receptor-mediated activation. Multiple isoforms of CD45 are distributed throughout the immune system and arise due to alternative splicing of exons located in the N-terminus. CD45RA contains the A exon and is a naive T-cell marker which may help prevent autoimmune disease. CD45RB contains B and stains most leukemias and lymphomas. CD45RC contains C and stains thymocytes, monocytes and dendritic cells. CD45RO doesn't contain A, B or C and is a marker of activated T-cells that can be used to classify and diagnose and classify lymphomas. Clone 2B11 antibody will bind to all CD45 isoforms. The variation in these isoforms is localized to the extracellular domain, with the intracellular domain being conserved. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3223-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3223-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3223SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3290-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3290-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
CD45 Antibody (Leukocyte marker) |
V3290SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: CD45R, also designated CD45 and PTPRC, has been identified as a transmembrane glycoprotein, broadly expressed among hematopoietic cells. Multiple isoforms of CD45R are distributed throughout the immune system according to cell type. These isoforms arise because of alternative splicing of exons 4, 5, and 6. The corresponding protein domains are characterized by the binding of monoclonal antibodies specific for CD45RA (exon 4), CD45RB (exon 5), CD45RC (exon 6) and CD45RO (exons 4 to 6 spliced out). The variation in these isoforms is localized to the extracellular domain of CD45R, while the intracellular domain is conserved. CD45R functions as a phosphor-tyrosine phosphatase. Antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. |
Cytoselect TM Leukocyte Transm.